A detailed history of Stifel Financial Corp transactions in Natera, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 11,524 shares of NTRA stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,524
Previous 4,483 157.06%
Holding current value
$1.69 Million
Previous $569,000 220.56%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$117.67 - $174.0 $828,514 - $1.23 Million
7,041 Added 157.06%
11,524 $1.82 Million
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $53,762 - $71,318
-550 Reduced 10.93%
4,483 $569,000
Q2 2024

Aug 13, 2024

SELL
$85.28 - $112.6 $37,693 - $49,769
-442 Reduced 8.07%
5,033 $545,000
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $92,959 - $145,853
1,570 Added 40.2%
5,475 $500,000
Q4 2023

Feb 12, 2024

BUY
$37.55 - $62.64 $146,632 - $244,609
3,905 New
3,905 $244,000
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $90,323 - $272,072
-2,979 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $28,034 - $38,675
-325 Reduced 9.84%
2,979 $278,000
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $7,011 - $8,845
-70 Reduced 2.07%
3,304 $368,000
Q2 2021

Aug 13, 2021

SELL
$86.05 - $119.72 $24,266 - $33,761
-282 Reduced 7.71%
3,374 $383,000
Q1 2021

May 14, 2021

BUY
$91.47 - $124.36 $11,799 - $16,042
129 Added 3.66%
3,656 $371,000
Q4 2020

Feb 12, 2021

BUY
$66.66 - $111.74 $35,929 - $60,227
539 Added 18.04%
3,527 $351,000
Q3 2020

Nov 16, 2020

BUY
$45.89 - $72.67 $137,119 - $217,137
2,988 New
2,988 $216,000
Q1 2020

May 14, 2020

SELL
$17.27 - $40.17 $256,183 - $595,881
-14,834 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$32.1 - $40.4 $476,171 - $599,293
14,834 New
14,834 $499,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.